Abstract |
E-type cyclins, collectively called cyclin E, represent key components of the core cell cycle machinery. In mammalian cells, two E-type cyclins, E1 and E2, activate cyclin-dependent kinase 2 (CDK2) and drive cell cycle progression by phosphorylating several cellular proteins. Abnormally elevated activity of cyclin E-CDK2 has been documented in many human tumor types. Moreover, cyclin E overexpression mediates resistance of tumor cells to various therapeutic agents. Recent work has revealed that the role of cyclin E extends well beyond cell proliferation and tumorigenesis, and it may regulate a diverse array of physiological and pathological processes. In this review, we discuss these various cyclin E functions and the potential for therapeutic targeting of cyclin E and cyclin E-CDK2 kinase.
|
Authors | Chen Chu, Yan Geng, Yu Zhou, Piotr Sicinski |
Journal | Trends in cell biology
(Trends Cell Biol)
Vol. 31
Issue 9
Pg. 732-746
(09 2021)
ISSN: 1879-3088 [Electronic] England |
PMID | 34052101
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
|
Copyright | Copyright © 2021 Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Animals
- Cell Cycle
- Cell Proliferation
- Cyclin E
(genetics)
- Cyclins
(genetics)
- Humans
|